TIFFANY SCHRECK: Open Payments
NPI 1265919302 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$442 in 10 payments from 5 companies in 2025. Trend: 2023 $390 · 2024 $311 · 2025 $442
Food & beverage: $442
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 2 | $185 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $113 |
| GlaxoSmithKline, LLC. | 3 | $73 |
| ANI Pharmaceuticals, Inc. | 3 | $55 |
| Amgen Inc. | 1 | $16 |
Products named: TEZSPIRE, NUCALA, PURIFIED CORTROPHIN GEL.
Industry payments across PA — which companies pay providers there.
